Biomaterials startup Zentraxa announce seed investment

Posted by 

SETsquared Bristol

Our member company and University of Bristol spin-out, Zentraxa, has raised capital investment from Future Planet Capital, BPEC and Science Angel Syndicate to develop their innovative Zentide platform for engineering bespoke biomaterials.

With generous support of their recently awarded Innovate UK grant, Zentraxa is rapidly moving towards contracted commercial concept development in both medical adhesives and personal care. They are partnering with two leading multi-billion-pound corporations in these high-potential and lucrative markets.

Zentraxa’s platform uses advanced scientific engineering to design precision peptide sequences with distinct functional properties that are commercially viable and can easily be integrated with existing systems. This could be in medicine, for example, skin bonding and wound care, or personal use, such as skin and hair.

This investment will further support product development and enable scale-up of their platform technology.

Jonathan Wogel, Executive Chair and Director of Zentraxa, says:

“We are excited to develop our technology in line with the needs of our new commercial partners and deliver innovative material solutions to people as soon as possible. The funding will allow us to move quickly and hit our production milestones effectively.”

Zentraxa’s platform, Zentide, is particularly effective at producing materials that are difficult to make. With proof-of-concept projects in the pipeline, and commercial scale development lined up behind them, Zentraxa aims to lead the charge in producing scalable, sustainable by design, innovative biomaterials to improve performance in everyday products.

Hassan Mahmudul, Associate at UK Innovation & Science Seed Fund, Future Planet Capital, says:

 “We are delighted to support Zentraxa on their journey to build scalable, sustainable biomaterials for health, industrial and personal uses. There are meaningful and wide-ranging applications for the innovative biomaterials that Zentraxa are creating. We look forward to seeing how Zentraxa progresses in the coming months.”

For more information, please visit

Recent News, Blogs and Stories

Resized for website thumbnail

Innovative tech companies announced for Tech-Xpo 2022

Sixteen of our member companies will exhibit and demo their innovative products at our flagship Tech-Xpo 2022 showcase on 29 June. The companies shortlisted to compete for Best Elevator Pitch award are:...
Neighbourly team at Engine Shed

Neighbourly move to Engine Shed following investment raise

Our alumni member, Neighbourly, the community investment and engagement platform, is moving into our SETsquared Bristol home, Engine Shed, following another successful funding round of £1.6 million led by Guinness...
GenomeKey lab

GenomeKey raise Innovate UK funding to drive life-saving next-gen sepsis diagnostic

Our member GenomeKey, has secured an Innovate UK Biomedical Catalyst research award of £950,000 towards faster diagnosis and treatment of sepsis, one of the world’s most deadly diseases. The funding will...


Fast track your technology business